CReST2

CReST 2 is a further randomised trial comparing patient quality of life after use of covered vs. uncovered stents for palliation of obstructing colorectal cancer. It aims to recruit 350 patients over 3 years. The Radiology lead is Andy Lowe, Taunton

The study opened in 2017, and aims to complete recruitment by mid 2020.

Please click here for further information.

Alternatively, you can contact the Birmingham Clinical Trials Unit via:

Birmingham Clinical Trials Unit
Institute of Applied Health Research
College of Medical and Dental Sciences
University of Birmingham
Birmingham
B15 2TT
United Kingdom
+44 121 415 9105
e.l.magill@bham.ac.uk

© Copyright 2021 BSGAR